With ₹176 crore raised and a 31% premium on debut, the dual listings reflect momentum in India’s SME investment ecosystem across specialty chemicals and HVAC...
Archive - 9 months ago
The move formalizes the company’s operational identity under BSE Ltd. and reinforces its role in maintaining India’s most referenced indices. Asia Index...
India’s fourth-largest pharma company posts strong domestic growth, 81.1% export surge, and 15% rise in consumer healthcare revenue led by flagship brands and...
